Zobrazeno 1 - 10
of 356
pro vyhledávání: '"MESH : Enzyme Inhibitors"'
Autor:
Michael Spedding, Alexandre Henriques, Frédérique René, Cyril Quessada, Alexandra Bouscary, Jean-Philippe Loeffler, Shyuan T. Ngo
Publikováno v:
European Journal of Pharmacology
European Journal of Pharmacology, 2020, 884, pp.173446. ⟨10.1016/j.ejphar.2020.173446⟩
European Journal of Pharmacology, Elsevier, 2020, 884, pp.173446. ⟨10.1016/j.ejphar.2020.173446⟩
European Journal of Pharmacology, 2020, 884, pp.173446. ⟨10.1016/j.ejphar.2020.173446⟩
European Journal of Pharmacology, Elsevier, 2020, 884, pp.173446. ⟨10.1016/j.ejphar.2020.173446⟩
International audience; Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease in adults. While it is primarily characterized by the death of upper and lower motor neurons, there is a significant metabolic component involved in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d5d2c9bf5526c8fda5405cf68e3ac9c
https://www.hal.inserm.fr/inserm-03376315/file/1-s2.0-S0014299920305380-main.pdf
https://www.hal.inserm.fr/inserm-03376315/file/1-s2.0-S0014299920305380-main.pdf
Autor:
Patricia Luz-Crawford, Carolina Pradenas, Farida Djouad, Mauricio Campos-Mora, Maroun Khoury, Karina Oyarce, Noymar Luque-Campos, Maria Jose Torres, María Jose Paredes-Martínez, Yandi Rigual-Gonzalez, Gautier Tejedor, María De Los Ángeles García-Robles, Christian Jorgensen, Roberto Elizondo-Vega, Rafael Contreras-Lopez, Claudia Altamirano, Magdiel Salgado, Ana María Vega-Letter
Publikováno v:
Theranostics
Theranostics, 2021, 11 (1), pp.445-460. ⟨10.7150/thno.51631⟩
Theranostics, 2021, 11 (1), pp.445-460. ⟨10.7150/thno.51631⟩
International audience; Objectives: Mesenchymal Stem/Stromal Cells (MSC) are promising therapeutic tools for inflammatory diseases due to their potent immunoregulatory capacities. Their suppressive activity mainly depends on inflammatory cues that ha
Autor:
Andrew G. Watts, A. Carlos Frasch, Ricardo Resende, Jean M. H. van den Elsen, Susan J. Crennell, Patricia Marcé, Pedro M. Alzari, Zexin Chen
Publikováno v:
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry, Elsevier, 2018, 158, pp.25-33. ⟨10.1016/j.ejmech.2018.08.089⟩
Chen, Z, Marce Villa, P, Resende, R, Alzari, P M, Frasch, A C, Van Den Elsen, J, Crennell, S & Watts, A 2018, ' The synthesis and kinetic evaluation of aryl α-aminophosphonates as novel inhibitors of T. cruzi trans-sialidase ', European Journal of Medicinal Chemistry, vol. 158, pp. 25-33 . https://doi.org/10.1016/j.ejmech.2018.08.089
European Journal of Medicinal Chemistry, 2018, 158, pp.25-33. ⟨10.1016/j.ejmech.2018.08.089⟩
European Journal of Medicinal Chemistry, Elsevier, 2018, 158, pp.25-33. ⟨10.1016/j.ejmech.2018.08.089⟩
Chen, Z, Marce Villa, P, Resende, R, Alzari, P M, Frasch, A C, Van Den Elsen, J, Crennell, S & Watts, A 2018, ' The synthesis and kinetic evaluation of aryl α-aminophosphonates as novel inhibitors of T. cruzi trans-sialidase ', European Journal of Medicinal Chemistry, vol. 158, pp. 25-33 . https://doi.org/10.1016/j.ejmech.2018.08.089
European Journal of Medicinal Chemistry, 2018, 158, pp.25-33. ⟨10.1016/j.ejmech.2018.08.089⟩
The trans-sialidase protein expressed by Trypanosoma cruzi is an important enzyme in the life cycle of this human pathogenic parasite and is considered a promising target for the development of new drug treatments against Chagas' disease. Here we des
Autor:
Guéant, Jean-Louis, Chéry, Céline, Oussalah, Abderrahim, Nadaf, Javad, Coelho, David, Josse, Thomas, Flayac, Justine, Robert, Aurélie, Koscinski, Isabelle, Gastin, Isabelle, Filhine-Tresarrieu, Pierre, Pupavac, Mihaela, Brebner, Alison, Watkins, David, Pastinen, Tomi, Montpetit, Alexandre, Hariri, Fadi, Tregouët, David, Raby, Benjamin A, Chung, Wendy K., Morange, Pierre-Emmanuel, Froese, D. Sean, Baumgartner, Matthias R., Benoist, Jean-François, Ficicioglu, Can, Marchand, Virginie, Motorin, Yuri, Bonnemains, Chrystèle, Feillet, François, Majewski, Jacek, Rosenblatt, David S.
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-12 (2018)
Nature Communications
Nature Communications, 2018, 9 (1), pp.67. ⟨10.1038/s41467-017-02306-5⟩
Nature Communications, Nature Publishing Group, 2018, 9 (1), pp.67. ⟨10.1038/s41467-017-02306-5⟩
Nature Communications
Nature Communications, 2018, 9 (1), pp.67. ⟨10.1038/s41467-017-02306-5⟩
Nature Communications, Nature Publishing Group, 2018, 9 (1), pp.67. ⟨10.1038/s41467-017-02306-5⟩
To date, epimutations reported in man have been somatic and erased in germlines. Here, we identify a cause of the autosomal recessive cblC class of inborn errors of vitamin B12 metabolism that we name “epi-cblC”. The subjects are compound heteroz
Autor:
Marie Octave, Laurence Pirotton, Audrey Ginion, Valentine Robaux, Sophie Lepropre, Jérôme Ambroise, Caroline Bouzin, Bruno Guigas, Martin Giera, Marc Foretz, Luc Bertrand, Christophe Beauloye, Sandrine Horman
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 2021, 22 (23), pp.13129. ⟨10.3390/ijms222313129⟩
International Journal of Molecular Sciences, 22(23). MDPI
International Journal of Molecular Sciences; Volume 22; Issue 23; Pages: 13129
International Journal of Molecular Sciences, Vol 22, Iss 13129, p 13129 (2021)
International journal of molecular sciences, Vol. 22, no. 23, p. 13129 [1-17] (2021)
International Journal of Molecular Sciences, 2021, 22 (23), pp.13129. ⟨10.3390/ijms222313129⟩
International Journal of Molecular Sciences, 22(23). MDPI
International Journal of Molecular Sciences; Volume 22; Issue 23; Pages: 13129
International Journal of Molecular Sciences, Vol 22, Iss 13129, p 13129 (2021)
International journal of molecular sciences, Vol. 22, no. 23, p. 13129 [1-17] (2021)
International audience; Acetyl-CoA carboxylase (ACC) is the first enzyme regulating de novo lipid synthesis via the carboxylation of acetyl-CoA into malonyl-CoA. The inhibition of its activity decreases lipogenesis and, in parallel, increases the ace
Autor:
Julie Paoletti, Gilles Labesse, Olivier Dussurget, Marie Anne Nahori, Liliane Assairi, Sylvie Pochet, Muriel Gelin, Valérie Huteau
Publikováno v:
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry, Elsevier, 2016, 124, pp.1041-1056. ⟨10.1016/j.ejmech.2016.10.033⟩
European Journal of Medicinal Chemistry, 2016, 124, pp.1041-1056. ⟨10.1016/j.ejmech.2016.10.033⟩
European Journal of Medicinal Chemistry, Elsevier, 2016, 124, pp.1041-1056. ⟨10.1016/j.ejmech.2016.10.033⟩
European Journal of Medicinal Chemistry, 2016, 124, pp.1041-1056. ⟨10.1016/j.ejmech.2016.10.033⟩
Increased resistance of pathogens to existing antibiotics necessitates the search for novel targets to develop potent antimicrobials. Biosynthetic pathways of several cofactors important for bacterial growth, such as nicotinamide adenine dinucleotide
Autor:
Roberta Mazzone, Piero Picci, Katia Scotlandi, Michela Pasello, Patrizia Nanni, Giordano Nicoletti, Maria Cristina Manara, Antonello Mai, Clara Guerzoni, Camilla Cristalli, Pier Luigi Lollini, Lorena Landuzzi, Sergio Valente, Giulia Stazi, Paola B. Arimondo, Clemens Zwergel
Publikováno v:
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics, American Association for Cancer Research, 2018, 17 (9), pp.1881-1892. ⟨10.1158/1535-7163.MCT-17-0818⟩
Molecular Cancer Therapeutics, American Association for Cancer Research, 2018, 17 (9), pp.1881-1892. ⟨10.1158/1535-7163.MCT-17-0818⟩
The identification of new therapeutic strategies against osteosarcoma, the most common primary bone tumor, continues to be a primary goal to improve the outcomes of patients refractory to conventional chemotherapy. Osteosarcoma originates from the tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e55d5482d55dc2ed43ad6818ec4cbf60
https://hal.archives-ouvertes.fr/hal-02383680
https://hal.archives-ouvertes.fr/hal-02383680
Publikováno v:
Bulletin du Cancer
Bulletin du Cancer, 2019, 106 (10), pp.823-833. ⟨10.1016/j.bulcan.2019.08.001⟩
Bulletin du Cancer, John Libbey Eurotext, 2019, 106 (10), pp.823-833. ⟨10.1016/j.bulcan.2019.08.001⟩
Bulletin du Cancer, 2019, 106 (10), pp.823-833. ⟨10.1016/j.bulcan.2019.08.001⟩
Bulletin du Cancer, John Libbey Eurotext, 2019, 106 (10), pp.823-833. ⟨10.1016/j.bulcan.2019.08.001⟩
International audience; Epigenetic regulation is altered in many diseases, in particular in cancer. Several molecules acting on the epigenetic regulation are in clinical trials, some of which are already approved for the treatment of haematological c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::eeca3281a8eca869b8cbbd7d40e10f31
https://hal.science/hal-02383686
https://hal.science/hal-02383686
Autor:
Cedric Couturier, Sylvie Goussard, Guillaume Duménil, Dorian Obino, Youxin Kong, Ximing Xu, Flore Aubey, Stéphane Renard, Catherine Lapeyrere, Judith Souphron, Jean-Philippe Corre
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2019, 116 (17), pp.8481-8486. ⟨10.1073/pnas.1817757116⟩
Proceedings of the National Academy of Sciences of the United States of America, 2019, 116 (17), pp.8481-8486. ⟨10.1073/pnas.1817757116⟩
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2019, 116 (17), pp.8481-8486. ⟨10.1073/pnas.1817757116⟩
Proceedings of the National Academy of Sciences of the United States of America, 2019, 116 (17), pp.8481-8486. ⟨10.1073/pnas.1817757116⟩
International audience; Despite the availability of antibiotics and vaccines, Neisseria meningitidis remains a major cause of meningitis and sepsis in humans. Due to its extracellular lifestyle, bacterial adhesion to host cells constitutes an attract
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3cd36dd5177d67e6129ff39dca8b82b
https://hal-pasteur.archives-ouvertes.fr/pasteur-03100484/file/Aubey_et_al-Author_manuscript-HAL_Pasteur.pdf
https://hal-pasteur.archives-ouvertes.fr/pasteur-03100484/file/Aubey_et_al-Author_manuscript-HAL_Pasteur.pdf
Autor:
Gilles Labesse, Olivier Helynck, Sophie Vichier-Guerre, Thomas Alexandre, Muriel Gelin, Hélène Munier-Lehmann, Alexandru Lupan, Laurence Dugué, Ahmed Haouz
Publikováno v:
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry, 2019, 167, pp.124-132. ⟨10.1016/j.ejmech.2019.01.064⟩
European Journal of Medicinal Chemistry, Elsevier, 2019, 167, pp.124-132. ⟨10.1016/j.ejmech.2019.01.064⟩
European Journal of Medicinal Chemistry, 2019, 167, pp.124-132. ⟨10.1016/j.ejmech.2019.01.064⟩
European Journal of Medicinal Chemistry, Elsevier, 2019, 167, pp.124-132. ⟨10.1016/j.ejmech.2019.01.064⟩
International audience; Inosine-5'-monophosphate dehydrogenase (IMPDH) is an essential enzyme in many bacterial pathogens and is considered as a potential drug target for the development of new antibacterial agents. Our recent work has revealed the c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bef6868bbbe746ea71fc1bb58c79ad2
https://hal-pasteur.archives-ouvertes.fr/pasteur-02125232/document
https://hal-pasteur.archives-ouvertes.fr/pasteur-02125232/document